Evidence map›Paper›PMID 24719333›Full record

ArticleThe Journal of biological chemistry2014

Hepatic scavenger receptor BI protects against polymicrobial-induced sepsis through promoting LPS clearance in mice.

Ling Guo, Zhong Zheng, Junting Ai, Bin Huang, Xiang-An Li

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. The Role of Scavenger Receptor BI in Sepsis.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Impact of High-Density Lipoproteins on Sepsis.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Scavenger Receptor BI Attenuates IL-17A-Dependent Neutrophilic Inflammation in Asthma.American journal of respiratory cell and molecular biology · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ling GuoFrom the Department of Pediatrics, Saha Cardiovascular Research Center.
Zhong ZhengFrom the Department of Pediatrics, Graduate Center for Nutritional Sciences, and.
Junting AiFrom the Department of Pediatrics, Graduate Center for Nutritional Sciences, and.
Bin HuangKentucky Cancer Registry, University of Kentucky College of Medicine, Lexington, Kentucky 40536.
Xiang-An LiFrom the Department of Pediatrics, Saha Cardiovascular Research Center, Kentucky Cancer Registry, University of Kentucky College of Medicine, Lexington, Kentucky 40536 xli2@email.uky.edu.
University of Kentucky · US

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers · 2013 to 2026
$38.3M
Role of SR-BI in LPS detoxificationR01GM085231 · NIGMS · UNIVERSITY OF KENTUCKY · PI LI, XIANG-AN · 2008 to 2012
$1.5M
NCI NIH HHS P30 CA177558NIGMS NIH HHS R01 GM085231NIGMS NIH HHS R01GM085231NIGMS NIH HHS R01GM085231-2S1NIGMS NIH HHS R01GM085231-5S1
6 · The paper itself

Abstract

Recent studies revealed that scavenger receptor BI (SR-BI or Scarb1) plays a critical protective role in sepsis. However, the mechanisms underlying this protection remain largely unknown. In this study, using Scarb1(I179N) mice, a mouse model specifically deficient in hepatic SR-BI, we report that hepatic SR-BI protects against cecal ligation and puncture (CLP)-induced sepsis as shown by 75% fatality in Scarb1(I179N) mice, but only 21% fatality in C57BL/6J control mice. The increase in fatality in Scarb1(I179N) mice was associated with an exacerbated inflammatory cytokine production. Further study demonstrated that hepatic SR-BI exerts its protection against sepsis through its role in promoting LPS clearance without affecting the inflammatory response in macrophages, the glucocorticoid production in adrenal glands, the leukocyte recruitment to peritoneum or the bacterial clearance in liver. Our findings reveal hepatic SR-BI as a critical protective factor in sepsis and point out that promoting hepatic SR-BI-mediated LPS clearance may provide a therapeutic approach for sepsis.

Indexed as

Adrenal GlandsAnimalsBlotting, WesternCecumCell LineCytokinesGlucocorticoidsImmunity, InnateLeukocytesLigationLipopolysaccharidesLiverMacrophagesMiceMice, Inbred C57BLPeritoneumCytokinesGlucocorticoidsLipopolysaccharidesScarb1 protein, mouseScavenger Receptors, Class BHigh Density Lipoprotein (HDL)ImmunologyLipopolysaccharide (LPS)Lipoprotein ReceptorScarb1SepsisSR-BI

Identifiers

PMID24719333
PMCPMC4031522
OpenAlexW1989192104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.